Cycrimine (CAS 77-39-4) Suppliers and Product Information

Cycrimine, also known by the trade name Pagitane, is a central anticholinergic drug used in the treatment of Parkinson's disease. It works by reducing acetylcholine levels and binding to the muscarinic acetylcholine receptor M1. Cycrimine is classified as a cholinolytic anti-Parkinson drug and can cause neuromuscular blockades in isolated rat diaphragms.

Frequently Asked Questions

Q: What is the main use of Cycrimine?

A: Cycrimine is primarily used in the treatment of Parkinson's disease. It acts as a central anticholinergic drug designed to reduce the levels of acetylcholine.

Q: What is the mechanism of action of Cycrimine?

A: Cycrimine works by binding to the muscarinic acetylcholine receptor M1, thereby reducing acetylcholine levels in the brain.

Q: Is Cycrimine available under any other names?

A: Yes, Cycrimine is also known by its trade name Pagitane.

Q: What is the chemical classification of Cycrimine?

A: Cycrimine is classified as a piperidine derivative. Specifically, it is a 3-(piperidin-1-yl)propan-1-ol in which one of the hydrogen atoms at the 1-position is substituted by cyclopentyl and the other by phenyl.